Company: RGNT
Filing Date: 2025-10-24
Form Type: F-1/A
Source: 0001213900-25-101900
Chunk: 310

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-10-24
Form: F-1/A
Chunk 310
---
 or entities pursuant to Regulation S or, in reliance upon the exemption from registration provided under
Section 4(a)(2) of the Securities Act and the regulations promulgated thereunder.

We claimed exemption from
registration under the Securities Act for the option grants described above under Section 4(a)(2), Regulation S, or under Rule 701
of the Securities Act as transactions pursuant to written compensatory plans or pursuant to a written contract relating to compensation.

No underwriters were employed
in connection with the securities issuances set forth in this Item.

<div align='center'>II-3</div>

Item 8. Exhibits and Financial Statement Schedules.

(a) Exhibits. See the Exhibit Index attached
to this registration statement, which is incorporated by reference herein.

(b) Financial Statement Schedules. Schedules
not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial
statements or notes thereto.

Item 9. Undertakings.

(a) The undersigned Registrant
hereby undertakes:

| (1) | To file, during any period                                                                          
 in which offers or sales are being made, a post-effective amendment to this registration statement: |

| i. | To include any prospectus                                   
 required by section 10(a)(3) of the Securities Act of 1933; |

| ii. | To reflect in the prospectus                                                                                                             
 any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) 
 which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.      
 Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities         
 offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering         
 range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes     
 in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation              
 of Registration Fee” table in the effective registration statement;                                                                      |

| iii. | To include any material                                                                                                            
 information with respect to the plan of distribution not previously disclosed in the registration statement or any material change 
 to such information in the registration statement.                                                                                 |

| (2) | That, for the purpose of                                                                                                                
 determining